Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
IU Angel Network
AddedFeb 17, 2024
UpdatedJun 28, 2026
IU Angel Network

IU Angel Network

Operating

Connecting startups with investors, IU Angel Network fosters entrepreneurship for Indiana's prosperity.

Location
Bloomington, IN, US
Founded
1997
Firm
Compare
Portfolio
Employees
Website

IU Angel Network focuses on connecting startup companies with prospective investors from Indiana University's global community, including alumni, faculty, staff, students, and friends. The network primarily targets early-stage investment opportunities, including pre-seed, seed, and Series A rounds. Typical investments range from smaller amounts like $50,000 to larger sums up to $2 million, reflecting their commitment to fostering entrepreneurship and contributing to the prosperity of Indiana and beyond.

Notable portfolio companies include Adipo Therapeutics, Amplified Sciences, Cardinal Spirits, Civic Champs, MetaCX, Probari, Scioto Biosciences, Stagetime, SummaForte, and TrueLeap. The IU Angel Network is led by key partners who are deeply embedded in the Indiana University ecosystem. Their investment philosophy centers on leveraging the university's extensive network to provide not only capital but also mentorship and strategic connections. This unique value-add service helps startups scale effectively while maintaining strong ties to Indiana University's mission of promoting a pervasive entrepreneurial culture.

IU Angel Network - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments13
Current Portfolio Count10
Total Portfolio Exits0

Top Investment Stages

Seed5 (41.7%)
Angel2 (16.7%)
Pre-Seed2 (16.7%)
Series Unknown2 (16.7%)
Convertible Note1 (8.3%)

Stage Mix

Seed 42%Angel 17%Pre-Seed 17%Series Unknown 17%Convertible Note 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Adipo Therapeutics logo

Adipo Therapeutics

TrueLeap logo

TrueLeap

Cardinal Spirits logo

Cardinal Spirits

MetaCX logo

MetaCX

Stagetime logo

Stagetime

Amplified Sciences logo

Amplified Sciences

SummaForte logo

SummaForte

Civic Champs logo

Civic Champs

Probari logo

Probari

Scioto Biosciences logo

Scioto Biosciences

IU Angel Network - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 3 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services
SIC
  • 6000Depository Institutions